Official Release: China’s Five-Year Survival Rate for Cancer Patients Aged 0-19 Reaches 77.2%, Multiple Achievements Reach International Advanced Levels
On December 24, 2025, a significant announcement concerning countless families drew widespread attention across society. The National Center for Children’s Cancer Surveillance released China's first-ever research data on the five-year survival rate for childhood and adolescent cancers. The related findings were simultaneously published in The Lancet, one of the world's top medical journals. The study reveals that the five-year survival rate for cancer patients aged 0-19 in China has increased to 77.2%, marking a significant improvement of 5.3 percentage points compared to a decade ago. Survival rates for several key cancer types far exceed the targets proposed by the World Health Organization (WHO), with some approaching levels seen in high-income countries. The release of this data not only fills a critical national gap in survival statistics for children and adolescents with cancer in China but also signifies a major milestone in the development of the country's childhood cancer prevention and treatment system.
I. Key Data Insights: Over Three-Fourths of Young Patients Achieve Long-Term Survival, with Strong Performance in Key Cancers
This study, completed under the guidance of the National Health Commission by the National Children’s Medical Center, the National Center for Children’s Cancer Surveillance, and a team led by Professor Ni Xin from Beijing Children’s Hospital affiliated with Capital Medical University, represents China’s first cohort study on the five-year survival rate and healthcare accessibility for cancer patients aged 0-19. It included 95,189 cases diagnosed between 2018 and 2020 within the National Children's Cancer Surveillance Network, covering 1,760 surveillance sites across all 31 provinces and effectively representing approximately 85% of newly diagnosed childhood and adolescent cancer cases nationwide. The data is highly representative and authoritative within China.
1. Overall Survival Rate: 77.2% Achieve Long-Term Survival, Marking Significant Improvement from a Decade Ago
The study clearly presents the core finding: the five-year survival rate for cancer patients aged 0-19 in China is 77.2%. This means that out of every 100 diagnosed childhood and adolescent cancer patients, more than 77 will survive healthily for five years or more, achieving the goal of long-term survival. Professor Ni Xin, Director of the National Center for Children’s Cancer Surveillance, pointed out that compared to the assessment results from a decade ago, this figure represents a significant increase of 5.3 percentage points, with particularly notable progress in areas such as leukemia and lymphoma, which are common childhood cancers.
2. Age and Gender Differences: Survival Rate Slightly Higher in Children than Adolescents, Minor Advantage for Girls
Analysis by age group shows subtle differences in survival rates: the five-year survival rate for the 0-14 age group is 77.8%, while it is 75.3% for the 15-19 adolescent group. The survival rate for children is 2.5 percentage points higher than for adolescents. This difference may be related to factors such as the distribution of cancer types in adolescents and challenges in care coordination.
Data analysis by gender shows that the cancer incidence rate is higher for boys (133.36 per million) than for girls (118.74 per million). However, the five-year survival rate for girls (79.0%) is slightly higher than for boys (75.8%). Regarding specific cancer types, the top three cancers by incidence for boys are leukemia, central nervous system tumors, and lymphoma, with five-year survival rates of 75.9%, 71.9%, and 85%, respectively. For girls, the top three are leukemia, central nervous system tumors, malignant epithelial tumors, and melanoma. Notably, the five-year survival rate for malignant epithelial tumors and melanoma in girls is as high as 93.2%.
3. Breakthroughs in Key Cancers: Survival Rates for 6 Priority Cancers Exceed 80%, Surpassing WHO Target
The WHO’s Global Initiative for Childhood Cancer identifies six priority cancers: acute lymphoblastic leukemia, Burkitt lymphoma, Hodgkin lymphoma, retinoblastoma, Wilms tumor, and low-grade glioma. The study shows that China's five-year survival rates for these six cancers all exceed 80%, with the highest reaching 93.8%, far surpassing the WHO’s 60% target.
Among all cancer types, retinoblastoma has the highest five-year survival rate at 91.2%. Survival rates for germ cell tumors (86.9%) and malignant epithelial tumors and melanoma (89%) are also among the highest. It is noteworthy that survival rates for neuroblastoma, retinoblastoma, and Hodgkin lymphoma are approaching levels seen in high-income countries, indicating that China's diagnosis and treatment technologies in these areas have achieved international standards. In contrast, malignant bone tumors have the lowest survival rate at 60.4%, with survival rates continuing to decline in the years following diagnosis. This remains a key challenge for future childhood cancer prevention and treatment efforts.
II. Behind the Improved Survival Rates: A Systemic Victory Supported by Multiple Policies and Medical System Improvements
The significant improvement in the five-year survival rate for childhood and adolescent cancers is not the result of a single factor but a systemic victory driven by multiple initiatives, including reforms in China's medical security system, improvements in the diagnosis and treatment system, and deeper research collaboration. Professor Ni Xin's team clearly identified five core driving forces:
1. National Policies for the Treatment of Major Diseases Providing a Safety Net
In recent years, China has included childhood malignancies such as leukemia and lymphoma in the scope of special national treatment programs for major diseases. By clarifying diagnosis and treatment pathways, standardizing treatment procedures, and strengthening quality control, the standardization and effectiveness of care have been significantly improved. Specialized protection policies for childhood cancer patients have enabled more children to receive standardized treatment promptly, reducing delays caused by non-standardized care.
2. Improvements in Medical Security and Cross-Provincial Settlement Systems
Ongoing reforms in the medical security system have included more drugs and treatment items related to childhood cancer in the national reimbursement list, effectively alleviating the financial burden on families. Simultaneously, the continuous improvement of cross-provincial medical settlement systems has broken down geographical barriers, allowing children from remote areas to conveniently access high-quality medical resources concentrated in major cities, preventing treatment abandonment due to cost or settlement issues. The study shows that 23.5% of childhood and adolescent cancer patients in China choose to receive their initial treatment across provincial borders. Their mortality risk is significantly lower than that of patients treated within their home province, a finding that fully demonstrates the critical value of improved healthcare accessibility.
3. Introduction and Implementation of Internationally Standardized Treatment Protocols
China has actively introduced internationally advanced childhood cancer treatment guidelines and standardized protocols, optimizing and adapting them based on the disease characteristics and physical conditions of domestic patients. This has led to the formation of standardized diagnosis and treatment pathways suited to China's context. Furthermore, through nationwide training and technical promotion, core diagnosis and treatment technologies have been disseminated to grassroots medical institutions, narrowing the treatment gap between different regions.
4. The National Children's Cancer Surveillance Network Laying a Solid Data Foundation
In 2019, the National Health Commission approved the establishment of the National Center for Children’s Cancer Surveillance to carry out standardized registration and management of childhood and adolescent cancer case information. As of December 2025, a surveillance network has been established covering all 31 provinces and 1,760 surveillance sites, covering approximately 85% of newly diagnosed cases nationwide. The establishment of this network not only provided a solid foundation for the release of this authoritative data but also offers precise data for subsequent treatment protocol optimization and policy formulation, achieving the goal of "data-driven precision prevention and treatment."
5. Multi-Center Collaborative Network Uniting Research and Treatment Efforts
By establishing a multi-center collaborative network led by the National Children's Medical Center, China has achieved cross-regional integration of childhood cancer diagnosis and treatment resources. Medical institutions share treatment experiences and conduct joint research, accelerating the clinical application of new technologies and drugs. The advantages of this collaborative network are particularly evident in the treatment of complex and severe cases, further elevating the overall standard of care.
III. Existing Challenges: Significant Regional Disparities, Optimization of Medical Resource Distribution Still Needed
Although China has made significant progress in improving survival rates for childhood and adolescent cancers, the study also reveals shortcomings in the current prevention and treatment system. The most prominent is the disparity in survival rates between regions. The data shows that the overall survival rate gradually increases from 72.6% in regions with a low Socio-Demographic Index (SDI) to 84.9% in regions with a high SDI. There is a clear positive correlation between regional economic development levels and survival rates, and this disparity is more pronounced among the adolescent population.
Further analysis reveals that 58.8% of patients seeking cross-provincial care flow to regions with a higher SDI, reflecting the structural imbalance in the distribution of medical resources in China. Although cross-provincial care significantly reduces mortality risk, this survival benefit is not evenly distributed. It remains closely tied to the socioeconomic development levels of the patient's residence and treatment location. Some patients in remote areas, due to transportation and economic factors, still struggle to access high-quality medical resources. This remains a key bottleneck constraining further improvement in survival rates.
Addressing this issue, the research team, for the first time through scenario modeling, quantified and proposed priorities for the "tiered allocation" of medical resources for childhood and adolescent cancers: less developed regions should prioritize building foundational capabilities, such as pathological diagnosis, to ensure timely and accurate diagnosis for patients. More developed regions should focus on improving treatment systems and the entire care continuum, enhancing the ability to treat complex and severe cases and provide long-term rehabilitation management.
IV. Future Directions: Multi-Dimensional Efforts to Build a More Equitable and High-Quality Prevention and Treatment System
To further narrow regional disparities and improve the overall level of prevention and treatment, Professor Ni Xin's team proposed multi-dimensional optimization recommendations, focusing on the following four core areas:
1. Improve the Balanced Distribution of Medical Resources
Establish regional childhood cancer diagnosis and treatment centers. Using a model of "core hospitals + primary care collaboration units," high-quality medical resources can be extended to resource-deficient areas. Simultaneously, establish standardized hierarchical referral pathways, allowing patients with mild conditions to receive standardized treatment at the primary level, while complex and severe cases can be quickly connected to high-quality resources through referrals, improving the efficiency of medical resource utilization.
2. Strengthen Diagnostic Capacity Building at the Primary Level
Promote the application of artificial intelligence-assisted diagnostic technologies in primary medical institutions to help primary care doctors quickly identify suspected cases and shorten the diagnosis cycle. Additionally, enhance professional training for primary healthcare personnel to improve their ability to recognize early symptoms of childhood cancers and their basic diagnosis and treatment skills, thereby improving the timeliness and standardization of care from the source.
3. Enhance the Medical Security and Social Support Systems
Further expand the scope of medical insurance coverage to include more items related to childhood cancer, such as rehabilitation therapy and psychological intervention, alleviating the long-term burden on families. Encourage the participation of social forces by establishing special assistance funds and public welfare projects for childhood cancer patients, providing economic support and life assistance to families in need.
4. Focus on Treatment Transition and Whole-Person Care for Adolescents
Addressing the slightly lower survival rate among adolescents, focus on improving the medical transition mechanism from childhood to adulthood to avoid treatment disruptions due to age-related transitions. Concurrently, build a comprehensive whole-person care system encompassing "diagnosis, treatment, rehabilitation, and long-term follow-up." This system should not only focus on patient survival but also prioritize their quality of life post-treatment, helping patients better reintegrate into family and society.
Conclusion: From "Survival" to "Quality Survival," Safeguarding Every Child's Hope for Life
The increase in the five-year survival rate for cancer patients aged 0-19 in China to 77.2% is a vivid reflection of the continuous improvement in China's medical security system and the ongoing advancement of diagnosis and treatment technologies. This achievement not only brings hope to countless families but also provides a "China approach" that can be referenced by other low- and middle-income countries in their global childhood cancer prevention and treatment efforts. Through national-level planning and guidance, robust support from the medical security system, the promotion of treatment standardization, and multi-center collaboration, the effectiveness of childhood cancer care can be significantly enhanced.
Looking ahead, with the continued progress in the balanced distribution of medical resources and the continuous improvement of whole-person care systems, China's childhood and adolescent cancer prevention and treatment work will shift from "pursuing survival rate improvement" to "pursuing quality survival." It is believed that with the joint efforts of policymakers, the medical community, and society, more and more childhood and adolescent cancer patients will overcome their illnesses, regain healthy childhoods, and every child's hope for life will be more securely safeguarded.
This article is curated from external sources and published by CHN Healthcare Network. The views expressed do not necessarily reflect the platform’s position. For copyright concerns regarding content or images, please contact us at info@healthcarechn.com for prompt resolution.